[Effects of Covid-19 Pandemic on the Vaccine Activities on a Reference Immunization Center in Treichville, Côte D'ivoire].

Effets de la Pandémie à Covid-19 sur les Activités Vaccinales D'un Centre de Vaccination de Référence de Treichville en Côte D'ivoire.
Abidjan Covid-19 Immunization Immunization services Ivory Coast National institute of public hygiene Observance Sub Saharan Africa Treichville

Journal

Medecine tropicale et sante internationale
ISSN: 2778-2034
Titre abrégé: Med Trop Sante Int
Pays: France
ID NLM: 9918227363206676

Informations de publication

Date de publication:
30 06 2021
Historique:
received: 06 07 2020
accepted: 26 04 2021
entrez: 19 5 2022
pubmed: 20 5 2022
medline: 21 5 2022
Statut: epublish

Résumé

Since March 11, 2020, Côte d'Ivoire has been affected by the coronavirus epidemic, declared that same day as pandemic by WHO. March 11, 2021, one year after the pandemic, Côte d'Ivoire has notified 36,824 cases of Covid-19 patients and among them 211 have died. As of May 31, 2020, Côte d'Ivoire had already notified 2,833 cases and 33 deaths. At that time, false rumors were circulating in Africa about the setting up of clinical trials on candidate vaccines. The impact of these rumors on the overall use of health services had to be measured and in particular on vaccination centers. The objective of this study was to determine the effects of the pandemic on the activities of the immunization services of the National Institute of Public Hygiene in Abidjan, which comprises four departments: International Vaccination Center, Community Vaccination Service, Rabies Center, and Vaccination Unit of the Expanded Program on Immunization. The study was based on activity reports of the immunization services. At the International Vaccination Center, activities fell by about 50% in March, 86% in April and 82% in May in comparison with 2018 and 2019. Activities of Community Vaccination Service decreased by about 26% in March and 99% in April and May. At the Rabies Control Center, this reduction was estimated at 38% in April and 45% in May. The highest losses were for yellow fever and meningitis vaccines. The drop in attendance at vaccination services could increase the risk of epidemics, especially yellow fever, which are recurrent in Abidjan. Intensive awareness and catch-up actions should be carried out and further studies performed to assess the impact of the pandemic on immunization activities.

Identifiants

pubmed: 35586581
doi: 10.48327/mtsibulletin.n1.2021.101
pmc: PMC9022758
pii:
doi:

Substances chimiques

Rabies Vaccines 0

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 SFMTSI.

Déclaration de conflit d'intérêts

Les auteurs ne déclarent aucun conflit d'intérêt.

Références

Med Sante Trop. 2013 Jan-Mar;23(1):66-71
pubmed: 23693032

Auteurs

H Attoh Touré (HA)

Institut national d'hygiène publique, Côte d'Ivoire, BPV 14, Abidjan, Côte d'Ivoire.
UFR sciences médicales d'Abidjan, 01 BP 166 Abidjan 01, Côte d'Ivoire.

S Noufe (S)

Institut national d'hygiène publique, Côte d'Ivoire, BPV 14, Abidjan, Côte d'Ivoire.

K R Oussou (KR)

Institut national d'hygiène publique, Côte d'Ivoire, BPV 14, Abidjan, Côte d'Ivoire.
UFR sciences médicales d'Abidjan, 01 BP 166 Abidjan 01, Côte d'Ivoire.

K N'Guessan (K)

Institut national d'hygiène publique, Côte d'Ivoire, BPV 14, Abidjan, Côte d'Ivoire.

S M Setchi (SM)

Institut national d'hygiène publique, Côte d'Ivoire, BPV 14, Abidjan, Côte d'Ivoire.

A M N Ano (AMN)

Institut national d'hygiène publique, Côte d'Ivoire, BPV 14, Abidjan, Côte d'Ivoire.
UFR sciences médicales d'Abidjan, 01 BP 166 Abidjan 01, Côte d'Ivoire.

I Tiembre (I)

Institut national d'hygiène publique, Côte d'Ivoire, BPV 14, Abidjan, Côte d'Ivoire.
UFR sciences médicales d'Abidjan, 01 BP 166 Abidjan 01, Côte d'Ivoire.

B V J Bénie (BVJ)

Institut national d'hygiène publique, Côte d'Ivoire, BPV 14, Abidjan, Côte d'Ivoire.
UFR sciences médicales d'Abidjan, 01 BP 166 Abidjan 01, Côte d'Ivoire.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH